(Q42345914)

27 October 2017

Xpert MTB/RIF false detection of rifampin-resistant tuberculosis from prior infection (English)

1 reference

27 October 2017

J Daniel Kelly

1

1 reference

27 October 2017

Shou-Yean Grace Lin

2

1 reference

27 October 2017

Pennan M Barry

3

1 reference

27 October 2017

Chris Keh

4

1 reference

27 October 2017

Julie Higashi

5

1 reference

27 October 2017

John Z Metcalfe

6

1 reference

27 October 2017

language of work or name

English

0 references

publication date

1 December 2014

1 reference

American Journal of Respiratory and Critical Care Medicine

27 October 2017

1 reference

27 October 2017

190

1 reference

27 October 2017

11

1 reference

27 October 2017

1316-1318

1 reference

False-positive Xpert® MTB/RIF assays in previously treated patients: need for caution in interpreting results.

27 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446205

Xpert MTB/RIF assay shortens airborne isolation for hospitalized patients with presumptive tuberculosis in the United States

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446205

Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446205

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446205

Availability of an assay for detecting Mycobacterium tuberculosis, including rifampin-resistant strains, and considerations for its use - United States, 2013.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446205

Antituberculosis drug resistance acquired during treatment: an analysis of cases reported in California, 1994-2006.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446205

False-positive rifampicin resistance on Xpert® MTB/RIF: case report and clinical implications.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446205

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446205

Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446205

Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446205

Diabetes is associated with drug-resistant tuberculosis in Eastern Taiwan

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446205

Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5446205

10.1164/RCCM.201408-1500LE

17 August 2018

Identifiers

DOI

1 reference

27 October 2017

1 reference

27 October 2017

PubMed publication ID

25436783

1 reference